Return to homepagePandemic Pact

SEVOFLURAN SEDATION IN PATIENTS WITH RESPIRATORY DISTRESS SYNDROME CAUSED BY COVID19 INFECTION.

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00096

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    RAFAEL BADENES QUILES

  • Research Location

    Spain

  • Lead Research Institution

    FUNDACION PARA LA INVESTIGACION DE HOSPITAL CLINICO DE LA COMUNIDAD VALENCIANA

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

TNF] alpha, IL-1beta, IL-6, IL-8) alveolar and plasma at the time of admission and on Day 2. The investigators who will perform the analyzes will be blind to the group assignment. This is an intention-to-treat test